This is especially meaningful my senior year to get this community together for something so fun and invigorating, CAB student leader Austin Kent said
Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history
pH sensitivity To confer pH sensitivity, lipids with ionizable group, such as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), are incorporated due to their fusogenic properties under acidic conditions
Plaintiffs report persistent vomiting, diarrhea, abdominal pain, and conditions requiring surgical intervention to repair